[go: up one dir, main page]

NO20055130L - Aminocykloheksyleter-forbindelser og deres anvendelse - Google Patents

Aminocykloheksyleter-forbindelser og deres anvendelse

Info

Publication number
NO20055130L
NO20055130L NO20055130A NO20055130A NO20055130L NO 20055130 L NO20055130 L NO 20055130L NO 20055130 A NO20055130 A NO 20055130A NO 20055130 A NO20055130 A NO 20055130A NO 20055130 L NO20055130 L NO 20055130L
Authority
NO
Norway
Prior art keywords
ether compounds
aminocyclohexyl ether
compounds
compositions
present
Prior art date
Application number
NO20055130A
Other languages
English (en)
Other versions
NO334094B1 (no
NO20055130D0 (no
Inventor
Gregory N Beatch
Michael J A Walker
Lewis Siu Leung Choi
Grace Jung
Yuzhong Liu
Bertrand Plouvier
Richard Wall
Jeff Zhu
Alexander Zolotoy
Anthony G M Barrett
Dough Ta Hung Chou
Tao Sheng
Sondro L Yong
Original Assignee
Cardiome Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiome Pharma Corp filed Critical Cardiome Pharma Corp
Publication of NO20055130D0 publication Critical patent/NO20055130D0/no
Publication of NO20055130L publication Critical patent/NO20055130L/no
Publication of NO334094B1 publication Critical patent/NO334094B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Aminocykloheksyleterforbindelser er beskrevet. Forbindelsene ifølge foreliggende oppfinnelse kan innføres i preparater og sett. Foreliggende oppfinnelse beskriver også anvendelse av forbindelsene og preparatene, som omfatter behandling av arytmi.
NO20055130A 2003-05-02 2005-11-02 Aminocykloheksyleter-forbindelser,fremgangsmåte for fremstilling av slike samt mellomprodukter, preparat omfattende slike forbindelser som medikament samt slike forbindelser for behandling av sykdom NO334094B1 (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US46715903P 2003-05-02 2003-05-02
US47608303P 2003-06-04 2003-06-04
US47591203P 2003-06-05 2003-06-05
US47588403P 2003-06-05 2003-06-05
US47644703P 2003-06-05 2003-06-05
US48965903P 2003-07-23 2003-07-23
US49339203P 2003-08-07 2003-08-07
PCT/US2003/034655 WO2004099137A1 (en) 2003-05-02 2003-10-31 Aminocyclohexyl ether compounds and uses thereof

Publications (3)

Publication Number Publication Date
NO20055130D0 NO20055130D0 (no) 2005-11-02
NO20055130L true NO20055130L (no) 2005-12-01
NO334094B1 NO334094B1 (no) 2013-12-09

Family

ID=33437310

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055130A NO334094B1 (no) 2003-05-02 2005-11-02 Aminocykloheksyleter-forbindelser,fremgangsmåte for fremstilling av slike samt mellomprodukter, preparat omfattende slike forbindelser som medikament samt slike forbindelser for behandling av sykdom

Country Status (21)

Country Link
US (3) US20070099983A1 (no)
EP (3) EP2298735A1 (no)
JP (2) JP4919661B2 (no)
KR (1) KR101059379B1 (no)
AT (2) ATE325789T1 (no)
AU (2) AU2003287378B2 (no)
BR (2) BR122018009866B8 (no)
CA (1) CA2524323C (no)
CY (1) CY1105137T1 (no)
DE (1) DE60305200T2 (no)
DK (1) DK1560812T3 (no)
ES (2) ES2375820T3 (no)
IL (2) IL171653A (no)
NO (1) NO334094B1 (no)
NZ (1) NZ543921A (no)
PL (1) PL227937B1 (no)
PT (1) PT1560812E (no)
RU (1) RU2478617C2 (no)
SG (2) SG2010079697A (no)
SI (1) SI1560812T1 (no)
WO (1) WO2004099137A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4334766B2 (ja) 1998-04-01 2009-09-30 カーディオム ファーマ コーポレイション アミノシクロヘキシルエーテル化合物およびその用途
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US20080063707A1 (en) * 2003-05-02 2008-03-13 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
ATE325789T1 (de) * 2003-05-02 2006-06-15 Cardiome Pharma Corp Aminocyclohexylether-verbindungen und deren verwendung
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
MXPA06011419A (es) 2004-04-01 2007-04-20 Cardiome Pharma Corp Profarmacos de compuestos moduladores de canales ionicos y usos de los mismos.
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
WO2005094897A2 (en) 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
WO2006138673A2 (en) 2005-06-15 2006-12-28 Cardiome Pharma Corp. Synthetic processes for the preparation of aminocyclohexyl ether compounds
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
EP1868598B1 (en) * 2004-11-08 2014-04-23 Cardiome Pharma Corp. A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human
MX2007005988A (es) * 2004-11-18 2007-07-10 Cardiome Pharma Corp Procedimiento sintetico para compuestos de eter aminociclohexilico.
WO2006075778A1 (en) * 2005-01-12 2006-07-20 Astellas Pharma Inc. Production method of optically active cyclohexane ether compounds
US7973176B2 (en) * 2005-08-23 2011-07-05 Kaneka Corporation Process for production of aralkyloxypyrrolidine derivative
JP5004073B2 (ja) * 2006-06-13 2012-08-22 東レ・ファインケミカル株式会社 光学活性ベンジルオキシピロリジン誘導体塩酸塩粉体及びその製造法
CA2627502C (en) 2005-10-31 2014-04-01 Toray Fine Chemicals Co., Ltd. Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
JP5004067B2 (ja) * 2005-10-31 2012-08-22 東レ・ファインケミカル株式会社 ベンジルオキシ含窒素環状化合物の製造法
JP2007131597A (ja) * 2005-11-11 2007-05-31 Toray Fine Chemicals Co Ltd ベンジルオキシピロリジン誘導体の製造方法
KR20100017648A (ko) * 2007-05-04 2010-02-16 카디오메 파마 코포레이션 부정맥을 막기 위한 이온 채널 조절 화합물의 지속 방출성 구강 제형 및 관련 방법
WO2012024104A2 (en) 2010-08-16 2012-02-23 Codexis, Inc. Biocatalysts and methods for the synthesis of (1r,2r)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine
CA2808098C (en) 2010-08-16 2020-03-10 Merck Sharp & Dohme Corp. Process for preparing aminocyclohexyl ether compounds
EP3174935B1 (de) * 2014-08-01 2023-06-21 Covestro Intellectual Property GmbH & Co. KG Copolycarbonat-zusammensetzungen mit cyclischen und linearen oligomeren und verbesserten optischen eigenschaften

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954380A (en) * 1958-11-26 1960-09-27 Us Vitamin Pharm Corp Piperazinocyclohexyl esters
US3218328A (en) * 1963-02-18 1965-11-16 U S Vitamin & Pharmacentical C Heterocyclic amino phenoxyacetic acids, acid addition salts and quaternary ammonium salts thereof
DE2259260A1 (de) 1972-12-04 1974-06-06 Merck Patent Gmbh Neue amine
US4145435A (en) * 1976-11-12 1979-03-20 The Upjohn Company 2-aminocycloaliphatic amide compounds
US4179501A (en) * 1976-11-12 1979-12-18 The Upjohn Company Analgesic N-(2-aminocycloaliphatic)azidobenzamides
DE2658401A1 (de) 1976-12-23 1978-07-06 Merck Patent Gmbh Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4656182A (en) 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
US4598087A (en) * 1983-12-06 1986-07-01 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
DE3517901A1 (de) * 1984-05-18 1985-12-12 Glaxo Group Ltd., London Aminocyclopentylether, ihre herstellung und pharmazeutische formulierung
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
DE3668268D1 (de) 1985-10-25 1990-02-22 Upjohn Co Verwendung von cis-n-(2-aminocycloaliphatische) benzen acetamid und benzamid zur herstellung von antikrampfmittel.
US5059620A (en) * 1985-12-27 1991-10-22 The Du Pont Merck Pharmaceutical Company Aryl substituted aminomethyl benzene derivatives
US4855316A (en) * 1988-02-18 1989-08-08 Warner-Lambert Company 1,2-diamino-4,5-dimethoxycyclohexyl amide analgesic compounds
AU626949B2 (en) 1988-12-06 1992-08-13 Warner-Lambert Company 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
US5051428A (en) * 1988-12-06 1991-09-24 Warner-Lambert Company 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
US4906655A (en) 1989-01-24 1990-03-06 Warner-Lambert Company Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
JPH02270864A (ja) 1989-04-12 1990-11-05 Asahi Glass Co Ltd フルオロカルバサイクリックヌクレオシドおよびその製造法
US5428031A (en) 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
ZA929008B (en) 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
CA2058502A1 (en) 1991-12-27 1993-06-28 David C. Horwell 2-amino-mono-methoxycyclohexyl amides useful as analgesics
EP0552386A1 (en) 1992-01-13 1993-07-28 Warner-Lambert Company 2-Amino-3 or 6-methoxycyclohexyl amide derivatives
US5506257A (en) * 1992-03-26 1996-04-09 University Of British Columbia Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
AU668932B2 (en) 1992-03-26 1996-05-23 University Of British Columbia, The Method of blocking sodium channels or neuronal tissue
GB9220286D0 (en) 1992-09-25 1992-11-11 Merck Sharp & Dohme Therapeutic agents
US5451596A (en) 1992-12-29 1995-09-19 Rhone Poulenc Rorer Pharmaceuticals Inc. Cycloalkyl amine bis-aryl squalene synthase inhibitors
US5747278A (en) * 1993-05-21 1998-05-05 California Institute Of Technology DNA encoding inward rectifier, G-protein activated, mammalian, potassium KGA channel and uses thereof
US5492825A (en) * 1993-08-06 1996-02-20 The Regents Of The University Of California Mammalian inward rectifier potassium channel cDNA, IRK1, corresponding vectors, and transformed cells
WO1995008544A1 (en) * 1993-09-24 1995-03-30 The University Of British Columbia Aminocyclohexylesters and uses thereof
GB9406043D0 (en) * 1994-03-26 1994-05-18 Smithkline Beecham Plc Compounds
US5441946A (en) 1994-04-14 1995-08-15 Rhone-Poulenc-Rorer Pharmaceuticals, Inc. Phosphonate derivatives of lipophilic amines
US5854268A (en) * 1994-08-02 1998-12-29 Merck Sharp & Dohme, Ltd. Azetidine, pyrrolidine and piperidine derivatives
ES2167457T3 (es) * 1994-09-19 2002-05-16 Fujisawa Pharmaceutical Co Nuevo uso medicinal de un antagonista de 5ht3.
US5556990A (en) 1994-12-16 1996-09-17 Rhone-Poulenc Rorer Pharmaceuticals Inc. Polyarylcarbamoylaza- and -carbamoylalkanedioic acids
WO1996023894A1 (de) 1995-02-03 1996-08-08 Basf Aktiengesellschaft Racematspaltung primärer und sekundärer heteroatomsubstituierter amine durch enzym-katalysierte acylierung
CA2244209C (en) 1996-01-25 2007-10-23 Schering Aktiengesellschaft Improved concentrated injection and infusion solutions for intravenous administration
US5646151A (en) 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
EP0912505A4 (en) 1996-06-27 2001-10-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US6180632B1 (en) * 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
TW536401B (en) 1997-09-03 2003-06-11 Cardiome Pharma Corp A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain
CN1278166A (zh) 1997-09-26 2000-12-27 诺特兰药品公司 局部麻醉或抗心律不齐同时产生止痛的氨基环己酰胺的对映体混合物
JP3773644B2 (ja) * 1998-01-06 2006-05-10 芝府エンジニアリング株式会社 接点材料
US6013830A (en) 1998-03-30 2000-01-11 Sepracor Inc. Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
JP4334766B2 (ja) 1998-04-01 2009-09-30 カーディオム ファーマ コーポレイション アミノシクロヘキシルエーテル化合物およびその用途
US6624761B2 (en) * 1998-12-11 2003-09-23 Realtime Data, Llc Content independent data compression method and system
US6979685B1 (en) * 1999-02-12 2005-12-27 Cardiome Pharma Corp. Cycloalkyl amine compounds and uses thereof
WO2000047547A2 (en) 1999-02-12 2000-08-17 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
WO2000051981A1 (en) 1999-03-04 2000-09-08 Nortran Pharmaceuticals Inc. Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics
US7507545B2 (en) * 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
CA2268590A1 (en) * 1999-04-12 2000-10-12 Nortran Pharmaceuticals Inc. Ion channel modulating compounds and uses thereof
US6150357A (en) 1999-05-10 2000-11-21 Merck & Co., Inc. Potassium channel agonists
JP4219590B2 (ja) * 2000-04-20 2009-02-04 エフ．ホフマン−ラ ロシュ アーゲー ピロリジン及びピペリジン誘導体並びに神経変性障害の治療のためのこれらの使用
CA2311483A1 (en) 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
US6521619B2 (en) * 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
US6498170B2 (en) * 2000-07-17 2002-12-24 Wyeth Cyclamine sulfonamides as β-3 adrenergic receptor agonists
US7057053B2 (en) * 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US20040049049A1 (en) * 2002-06-14 2004-03-11 Johnson Matthey Pharmaceutical Materials, Inc. Stereoselective synthesis of 1,2-disubstituted cycloalkyls
GB2407093A (en) 2002-07-12 2005-04-20 Cardiome Inc Mutations of voltage-gated potassium channels
ATE325789T1 (de) 2003-05-02 2006-06-15 Cardiome Pharma Corp Aminocyclohexylether-verbindungen und deren verwendung
US7345086B2 (en) * 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
WO2004098525A2 (en) 2003-05-02 2004-11-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
US20060094880A9 (en) * 2003-06-04 2006-05-04 Barrett Anthony G M Synthetic process for trans-aminocyclohexyl ether compounds
WO2005018635A2 (en) * 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US20070197632A1 (en) 2003-10-31 2007-08-23 Cardiome Pharma Corp Aminocyclohexyl ether compounds and uses thereof
US7345087B2 (en) * 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof

Also Published As

Publication number Publication date
ATE325789T1 (de) 2006-06-15
AU2003287378A1 (en) 2004-11-26
ES2375820T3 (es) 2012-03-06
PL378918A1 (pl) 2006-06-12
NZ543921A (en) 2008-11-28
JP2006525227A (ja) 2006-11-09
BR0318278A (pt) 2006-05-23
RU2008104198A (ru) 2009-08-10
AU2011201015A1 (en) 2011-03-31
SG167670A1 (en) 2011-01-28
US7767830B2 (en) 2010-08-03
EP1560812B1 (en) 2006-05-10
US20070254945A1 (en) 2007-11-01
HK1091814A1 (zh) 2007-01-26
US20070099983A1 (en) 2007-05-03
KR20060057531A (ko) 2006-05-26
WO2004099137A1 (en) 2004-11-18
RU2478617C2 (ru) 2013-04-10
SG2010079697A (en) 2016-09-29
NO334094B1 (no) 2013-12-09
NO20055130D0 (no) 2005-11-02
JP4919661B2 (ja) 2012-04-18
US8163938B2 (en) 2012-04-24
CY1105137T1 (el) 2010-03-03
CA2524323C (en) 2012-05-15
IL171653A (en) 2013-06-27
DE60305200D1 (de) 2006-06-14
PL227937B1 (pl) 2018-01-31
EP1666459A3 (en) 2006-09-20
DK1560812T3 (da) 2006-09-04
EP2298735A1 (en) 2011-03-23
EP1560812A1 (en) 2005-08-10
US20110004006A1 (en) 2011-01-06
BRPI0318278B8 (pt) 2024-01-09
EP1666459B1 (en) 2011-10-19
ES2264776T3 (es) 2007-01-16
AU2003287378B2 (en) 2010-12-16
BR122018009866B1 (pt) 2018-12-18
IL216579A (en) 2015-02-26
PT1560812E (pt) 2006-09-29
BRPI0318278B1 (pt) 2018-11-06
KR101059379B1 (ko) 2011-08-26
SI1560812T1 (sl) 2006-10-31
BR122018009866B8 (pt) 2021-07-27
CA2524323A1 (en) 2004-11-18
ATE529401T1 (de) 2011-11-15
EP1666459A2 (en) 2006-06-07
IL216579A0 (en) 2012-01-31
DE60305200T2 (de) 2007-05-10
AU2011201015B2 (en) 2012-02-02
JP2007077162A (ja) 2007-03-29

Similar Documents

Publication Publication Date Title
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
EA200700225A1 (ru) Аналоги тетрапептида
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
MY142777A (en) Substituted indole-o-glucosides
UA85559C2 (en) Aminobenzophenone compounds
UA87991C2 (en) Substituted indole-o-glucosides
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
WO2006086562A3 (en) Phenylazetidinone derivatives
NO20060978L (no) Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering
TW200732349A (en) Anti-OX40L antibodies and methods using same
NO20090596L (no) Antivirale fosfinatforbindelser
MXPA05009885A (es) Nuevas triazolonas fusionadas y los usos de las mismas.
WO2005074598A3 (en) Nitroxyl progenitor compounds and methods of use
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
TW200716088A (en) Formulations and methods for treating amyloidosis
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
WO2005117543A3 (en) N-sulfonylcarboximidamide apoptosis promoters
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
ATE391489T1 (de) Haarbehandlungszusammensetzungen
TW200621260A (en) Selected fused heterocyclics and uses thereof
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: CORREVIO INTERNATIONAL SARL, CH

CREP Change of representative

Representative=s name: PROTECTOR IP AS, OSCARS GATE 20, 0352 OSLO, NORGE

MK1K Patent expired